Biotech IPO Challenges, ShareChat's Growth Amidst Tensions, and Privacy Complaints Against Google

The start-up that owns the biotechnology behind the Oxford/AstraZeneca vaccine has confidentially filed for an initial public offering in the US, Indian social media group ShareChat has raised more than $500m to grow its popular short-video app Moj, and Austrian activist Max Schrems has filed a privacy complaint against Google in France. Plus, the FT’s Washington bureau chief James Politi has details on the US’s offer to the rest of the world to tax multinational companies. 

US offers new plan in global corporate tax talks

https://www.ft.com/content/847c5f77-f0af-4787-8c8e-070ac6a7c74f

Biotech start-up behind AstraZeneca vaccine files for US listing 

https://www.ft.com/content/ff260c57-66f9-474b-9643-7640dc918009

ShareChat valued at $2bn in wake of TikTok ban 

https://www.ft.com/content/3a5e44e2-b2c0-4f37-9c4a-f51c6ef46eb6?

Max Schrems accuses Google of illegally tracking Android users

https://www.ft.com/content/4617cc99-3ed2-49e1-b97f-db4f1b45b5db?

Hosted on Acast. See acast.com/privacy for more information.